Whole exome sequencing, 90% at 20X in blood for NCI (hahn 2)

Ended Awarded Last action

Contract number
75N92022F00001
Awardee
Awarding agency
Obligated
$1,806,600

Award facts

Contract value 100% obligated
$1,806,600.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
National Cancer Institute National Institutes of Health, Department of Health and Human Services
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Baltimore, MD 21218, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00003 · Whole exome sequencing, 90% at 20X in blood for NCI (hahn 2), high throughput genotyping and DNA sequencing for studying the genetic contributions to human… $0
Other Administrative Action P00002 $0
Definitize Change Order P00001 $0
Original award $1,806,600

About this award

The U.S. National Cancer Institute (NCI) awarded a $1,806,600.00 firm fixed-price delivery order contract to The Johns Hopkins University for "WHOLE EXOME SEQUENCING, 90% AT 20X IN BLOOD FOR NCI (HAHN 2)." This contract has a period of performance through December 31, 2025. The Johns Hopkins University, a private research university located in Baltimore, Maryland, was selected for this award without a set-aside designation. As a leading institution in biomedical research, The Johns Hopkins University has a history of providing clinical trial coordination, data analysis, and subject matter expertise to federal agencies like the NCI, CDC, DoD, and DoJ through prime and subcontract awards.

Quick answers

Who was awarded contract 75N92022F00001?

75N92022F00001 was awarded to The Johns Hopkins University by National Heart Lung and Blood Institute (National Institutes of Health) on February 23, 2022.

How much is contract 75N92022F00001 worth?

The government has obligated $1,806,600 on 75N92022F00001.

Which agency awarded contract 75N92022F00001?

National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92022F00001, with funding from National Cancer Institute (National Institutes of Health).

Is contract 75N92022F00001 an order under another contract?

Yes. 75N92022F00001 is a delivery order under HHSN268201700006I, an indefinite delivery contract.

Was contract 75N92022F00001 competed?

The extent of competition for 75N92022F00001 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award